DR info

Clinical trials : 5 / Drugs : 6 - (DrugBank : 6) / Drug target genes : 8 - Drug target pathways : 12

Tricuspid atresia and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
212	Tricuspid atresia
13	Multiple sclerosis/Neuromyelitis optica
78	Hypopituitarism
210	Single Ventricle
323	Aromatic L-amino acid decarboxylase deficiency
211	Hypoplastic left heart syndrome
21	Mitochondrial disease
90	Retinitis pigmentosa
113	Muscular dystrophy
226	Interstitial cystitis with Hunners ulcer
96	Crohn disease
2	Amyotrophic lateral sclerosis
46	Malignant rheumatoid arthritis
6	Parkinson disease
139	Congenital cerebral hypomyelination
118	Myelomeningocele
169	Menkes disease
170	Occipital horn syndrome
280	Huge arteriovenous malformation with cervicofacial or limb lesion
80	Resistance to thyroid hormone
215	Tetralogy of Fallot
288	Autoimmune acquired coagulation factor deficiency
4	Primary lateral sclerosis
254	Porphyria
22	Moyamoya disease
11	Myasthenia gravis
107	Juvenile idiopathic arthritis
206	Fragile X syndrome
17	Multiple system atrophy
222	Primary nephrotic syndrome
5	Progressive supranuclear palsy
70	Spinal stenosis
84	Sarcoidosis
8	Huntington disease
34	Neurofibromatosis
65	Primary immunodeficiency
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
51	Scleroderma
49	Systemic lupus erythematosus
47	Buerger disease